Dashboard
Manage Tickers

HALO


()    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

hc-wainwright--co-reiterates-buy-on-halozyme-therapeutics-maintains-65-price-target
HC Wainwright & Co. Reiterates Buy on Halo...
09/16/2024 10:49:01

HC Wainwright & Co. analyst Mitchell Kapoor reiterates Halozyme Therapeutics (NASDAQ:HALO) with a Buy and maintains $65 ...

halo---analyzing-halozyme-therapeuticss-short-interest
(HALO) - Analyzing Halozyme Therapeutics's...
09/13/2024 19:00:21

Core News & Articles
Roche Group's Genentech Announces FDA Appr...
09/13/2024 17:24:02

– Ocrevus Zunovo™ has the potential to expand treatment options to centers without IV infrastructure or with IV constraints, li...

critical-insights-from-halozyme-therapeutics-analyst-ratings-what-you-need-to-know
Critical Insights From Halozyme Therapeuti...
09/13/2024 12:01:08

hc-wainwright--co-reiterates-buy-on-halozyme-therapeutics-maintains-65-price-target
HC Wainwright & Co. Reiterates Buy on Halo...
09/13/2024 10:36:11

HC Wainwright & Co. analyst Mitchell Kapoor reiterates Halozyme Therapeutics (NASDAQ:HALO) with a Buy and maintains $65 ...

Core News & Articles
Reported Earlier, Roche's Genentech And Ha...
09/13/2024 07:15:53

– Tecentriq Hybreza provides patients and physicians with greater flexibility of treatment options while showing safety and eff...

top-2-health-care-stocks-that-may-plunge-in-august
Top 2 Health Care Stocks That May Plunge I...
08/26/2024 11:53:01

how-is-the-market-feeling-about-halozyme-therapeutics
How Is The Market Feeling About Halozyme T...
08/20/2024 13:15:24

benchmark-reiterates-buy-on-halozyme-therapeutics-maintains-60-price-target
Benchmark Reiterates Buy on Halozyme Thera...
08/08/2024 15:50:09

Benchmark analyst Robert Wasserman reiterates Halozyme Therapeutics (NASDAQ:HALO) with a Buy and maintains $60 price target.

hc-wainwright--co-reiterates-buy-on-halozyme-therapeutics-maintains-65-price-target
HC Wainwright & Co. Reiterates Buy on Halo...
08/08/2024 10:50:15

HC Wainwright & Co. analyst Mitchell Kapoor reiterates Halozyme Therapeutics (NASDAQ:HALO) with a Buy and maintains $65 ...

td-cowen-maintains-buy-on-halozyme-therapeutics-raises-price-target-to-65
TD Cowen Maintains Buy on Halozyme Therape...
08/07/2024 21:13:31

TD Cowen analyst Brendan Smith maintains Halozyme Therapeutics (NASDAQ:HALO) with a Buy and raises the price target from $59...

morgan-stanley-maintains-overweight-on-halozyme-therapeutics-raises-price-target-to-64
Morgan Stanley Maintains Overweight on Hal...
08/07/2024 16:25:32

Morgan Stanley analyst Vikram Purohit maintains Halozyme Therapeutics (NASDAQ:HALO) with a Overweight and raises the price t...

halozyme-therapeutics-sees-fy24-eps-365-405-vs-399-est-revenue-935m-1015b-vs-98987m-est
Halozyme Therapeutics Sees FY24 EPS $3.65-...
08/06/2024 20:13:26

Financial Outlook for 2024The Company is reiterating its financial guidance for 2024, which was increased on June 6, 2024 as a ...

halozyme-therapeutics-q2-adj-091-beats-078-estimate-sales-23135m-beat-20890m-estimate
Halozyme Therapeutics Q2 Adj $0.91 Beats $...
08/06/2024 20:02:11

Halozyme Therapeutics (NASDAQ:HALO) reported quarterly earnings of $0.91 per share which beat the analyst consensus estimate of...

jp-morgan-maintains-overweight-on-halozyme-therapeutics-lowers-price-target-to-52
JP Morgan Maintains Overweight on Halozyme...
08/06/2024 16:21:00

JP Morgan analyst Jessica Fye maintains Halozyme Therapeutics (NASDAQ:HALO) with a Overweight and lowers the price target fr...

halo---analyzing-halozyme-therapeuticss-short-interest
(HALO) - Analyzing Halozyme Therapeutics's...
08/01/2024 17:30:16

analyst-scoreboard-14-ratings-for-halozyme-therapeutics
Analyst Scoreboard: 14 Ratings For Halozym...
08/01/2024 12:01:38

hc-wainwright--co-reiterates-buy-on-halozyme-therapeutics-maintains-65-price-target
HC Wainwright & Co. Reiterates Buy on Halo...
08/01/2024 10:51:35

HC Wainwright & Co. analyst Mitchell Kapoor reiterates Halozyme Therapeutics (NASDAQ:HALO) with a Buy and maintains $65 ...

goldman-sachs-maintains-neutral-on-halozyme-therapeutics-raises-price-target-to-49
Goldman Sachs Maintains Neutral on Halozym...
07/22/2024 13:33:31

Goldman Sachs analyst Graig Suvannavejh maintains Halozyme Therapeutics (NASDAQ:HALO) with a Neutral and raises the price ta...

what-13-analyst-ratings-have-to-say-about-halozyme-therapeutics
What 13 Analyst Ratings Have To Say About ...
07/16/2024 12:00:22

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION